Unique ID issued by UMIN | UMIN000000568 |
---|---|
Receipt number | R000000680 |
Scientific Title | Evaluation of Clinical Effectiveness of High-dose Intravenous Immunoglobulin(HD-IVIg) Therapy in Pneumonia with Avian Influenza and Other Influenza |
Date of disclosure of the study information | 2006/12/29 |
Last modified on | 2007/07/18 09:52:06 |
Evaluation of Clinical Effectiveness of High-dose Intravenous Immunoglobulin(HD-IVIg) Therapy in Pneumonia with Avian Influenza and Other Influenza
High-dose intravenous immunoglobulin(HD-IVIg) therapy in Pneumonia with severe Avian Influenza and other severe Influenza
Evaluation of Clinical Effectiveness of High-dose Intravenous Immunoglobulin(HD-IVIg) Therapy in Pneumonia with Avian Influenza and Other Influenza
High-dose intravenous immunoglobulin(HD-IVIg) therapy in Pneumonia with severe Avian Influenza and other severe Influenza
Japan | Asia(except Japan) |
Severe avian influenza and other severe influenza pneumonia
Pneumology | Infectious disease |
Others
NO
To examine the effectiveness of the treatment with the High-dose Intravenous immunoglobulin(HD-IVIg) for patients with avian influenza and other influenza pneumonia of moderate and severe cases in Vietnam and Japan.
Safety,Efficacy
Survival at day 5, day 10 and day 30 after start of the treatment.
If possible, the usefulness of this method for treatment will be compeared with historical cases.
Feaver,X-ray,and Chest CT findings, laboratory data, blood chemistry, blood gas analysys MPO and Cytokines levels in serum.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Medicine |
High dose immunoglobulin 2g/kg/BW/day in addition to the basic therapy
Not applicable |
Not applicable |
Male and Female
1. Criteria of moderate and severe pneumonia
-Necessity of hospitalization (decided by a clinical doctor)
-And some symptoms, such as fever, cough, breathlessness.
-And one of the four following clinical findings.
1)New infilitration lesion detected on the first CXR or newly occurred among the film series.
2)Dyspnea, which manifests by:
Rapid breath rate defined by
30/min for adults and children more than 12 y.o.
40/min for children from 7 - 12y.o.
45/min for children from 4 - 6 y.o.
50/min for children from 1 - 3 y.o.
3)Respiratory muscle retraction.
4)SpO2 < 92% or Pa02 < 80 Torr
2. Criteria for definitive avian influenza pneumonia: The definitive diagnosis is made when the patient:
a) is diagnosed as moderate or severe pneumonia following the above-mentioned criteria.
b) and H5N1 positive
3. Criteria for definitive other influenza pneumonia: The definitive diagnosis is made when the patient:
a) is diagnosed as moderate or severe pneumonia following the above-mentioned criteria.
b) and test of other influenza viruses reveals positive
4. Criteria for suspected avian influenza pneumonia: when the patient:
a) is diagnosed as moderate or severe pneumonia following the above-mentioned criteria.
b) has a contact history with sick or died poultry
5. Criteria for suspected other influenza pneumonia; when the patient
a) is diagnosed as moderate or severe pneumonia following the above-mentioned criteria.
b) has a contact history with other influenza cases.
1) Individuals who do not meet the above mentioned criteria for cases.
2) Individuals who do not agree to sign the informed consents
3) Individuals who suffer from side effect(s) of H-IVIg and have to stop the transfusion.
4) Individuals who are transferred to other hospitals/departments which make the observation impossible.
5) Individuals who suffer from underlying diseases, which become severe when they get this disease(avian or other human influenza pneumonia)
6) Individual with Severe congestive heart failure
7) Individual with IgA deficiency
8)Individual with risk of thrombo-embolism
9)Individual with hemolytic anemia
10) Individual with Immune deficiency
15
1st name | |
Middle name | |
Last name | Koichiro Kudo/Nguen Duc Hien |
International Medical Center of Japan (IMCJ)<Japan>
National Institute for Infectious and Tropical Disease(NIITD)<Vietnam>
Disease Control and Prevention Center (DCC) / National Institute for Infectious and Tropical Disease(NIITD)
1-21-1 Toyama, Shinjyuku-ku, Tokyo, Japan(DCC) / 78 Giai Phong Str-Hanoi, Vietnam(NIITD)
1st name | |
Middle name | |
Last name | Koichiro Kudo |
International Medical Center of Japan (IMCJ)
Disease Control and Prevention Center (DCC)
kkudo@imcj.hosp.go.jp
Japan:
International Medical Center of Japan
Vietnam:
National Institute for Infectious and Tropical Diseases, Bach Mai hospital, National Hospital of Pediatrics and other hospitals in Vietnam.
RIKEN Center of Research Network for Infectious Diseases (CRNID),Japanese Ministry of Education Culture, Sports, Service and Technology.
NO
2006 | Year | 12 | Month | 29 | Day |
Unpublished
The suspected case was entried as the first one in the trial study at NIITD Hanoi, Vietnam, June 2007.
2006 | Year | 05 | Month | 16 | Day |
2006 | Year | 08 | Month | 01 | Day |
2008 | Year | 05 | Month | 01 | Day |
2006 | Year | 12 | Month | 28 | Day |
2007 | Year | 07 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000680
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |